STOCK TITAN

Ellington Financial Inc. 10-Q Filings

EFC NYSE

Every 10-Q that Ellington Financial Inc. (EFC) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow EFC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EFC filings page.

Rhea-AI Summary

Ellington Financial Inc., a mortgage-focused REIT, reported significantly higher profitability for the six months ended June 30, 2026. Net income attributable to common stockholders rose to $149.9 million from $74.6 million a year earlier, and basic and diluted EPS increased to $1.21 from $0.80.

Total net interest income improved to $133.5 million for the six-month period, compared with $86.6 million in 2025, supported by higher interest income on a larger loan and securities portfolio. Total assets reached $21.0 billion at June 30, 2026, up from $19.4 billion at year-end 2025, driven largely by growth in reverse mortgage and residential loan holdings.

Total stockholders’ equity increased to $2.0 billion, with common shares outstanding rising to 127.6 million, reflecting ongoing equity issuance. The company continues to operate through its Investment Portfolio and Longbridge segments, using extensive fair-value accounting and derivative hedging to manage a complex, largely Level 3 mortgage and securitization platform while maintaining REIT tax status.

Rhea-AI Summary

Ellington Financial Inc. reported sharply higher profitability for the quarter ended March 31, 2026. Net income attributable to common stockholders rose to $95.5 million from $31.6 million a year earlier, with basic and diluted EPS increasing to $0.78 from $0.35.

Total net interest income grew to $61.3 million from $43.3 million, helped by higher interest income on a larger loan and securities portfolio. Total assets expanded to $20.23 billion from $19.35 billion at year-end 2025, driven mainly by growth in reverse mortgage and residential loan holdings.

The company generated $110.0 million of other income, including $17.0 million of litigation settlement income and sizable fair value gains related to HECM reverse mortgage loans and HMBS obligations. Operating leverage widened as total expenses increased to $80.4 million from $52.0 million, reflecting higher compensation, incentive fees, and transaction-related costs.

Stockholders’ equity attributable to common and preferred shareholders rose to $1.92 billion, supported by net income and $154.6 million of net common stock issuance, partly offset by $48.6 million of common dividends, $5.9 million of preferred dividends, and a $115.0 million preferred stock redemption.

Rhea-AI Summary

Ellington Financial Inc. reports solid growth for the quarter ended September 30, 2025. Total assets rose to $17.8 billion from $16.3 billion, driven mainly by loans at fair value, which increased to $15.5 billion. HMBS-related obligations grew to $10.1 billion, reflecting expansion in the reverse mortgage business.

Quarterly net interest income improved to $49.7 million from $33.6 million a year earlier. Net income attributable to common stockholders increased to $29.5 million, or $0.29 per share, compared with $16.2 million, or $0.19 per share. For the first nine months of 2025, net income attributable to common stockholders was $104.1 million versus $95.4 million in 2024. Operating cash flow was negative, while financing activities provided significant cash as the company issued common stock and added secured borrowings. Common shares outstanding reached 106.1 million as of September 30, 2025.

Rhea-AI Summary

Ellington Financial Inc. reported consolidated assets of $17,071,895 (in thousands) and total liabilities of $15,382,385 as of June 30, 2025, up from $16,317,028 and $14,726,206 at December 31, 2024, respectively. The Company held $211,013 of cash and $19,617 of restricted cash (in thousands) and recorded $14,668,365 in loans, at fair value. Investments in unconsolidated entities increased to $307,722 from $220,078.

For the three months ended June 30, 2025 the Company reported net interest income of $43,343 (in thousands) and total other income (loss) of $49,199. Total expenses were $57,066, producing net income of $51,073 and net income attributable to common stockholders of $42,923. Basic and diluted EPS for the quarter were $0.45 (compared with $0.62 a year earlier). For the six months, net income was $90,397 and EPS was $0.80.

Key balance sheet and financing items include HMBS-related obligations of $9,814,811, repurchase agreements and reverse repurchase activity supporting portfolio financings, and total equity of $1,689,510. The registrant reported 99,893,894 common shares outstanding as of August 8, 2025. (All dollar amounts presented in the filings are expressed in thousands.)